As add-on treatment to metformin HCl, dapagliflozin 10 mg provided statistically significant improvements in HbA1c and FPG, and statistically significant reduction in body weight compared with placebo at Week 24 (see Table 13 and Figure 3)
Mechanism: Alpha-lipoic acid appears to enhance glucose uptake by activating AMP-activated protein kinase (AMPK), a master metabolic regulator, and by improving insulin receptor signaling
Working closely with your healthcare provider during this time makes sure your treatment plan fits your medical history and current health conditions
Another option may be to switch to another GLP-1 medication or try alternative weight loss treatment such as tirzepatide
Consequently, therapeutic strategies focus on rectifying metabolic abnormalities
These compounded versions differ from FDA-approved medications: They bypass the strict FDA new drug approval process and are not reviewed by the FDA for safety, efficacy, or manufacturing quality